FDA Authorizes Pfizer’s Paxlovid, First Oral Therapy for COVID-19
Given within three days of symptom onset, the pill combination was nearly 90 percent effective at preventing high-risk patients from developing severe illness in a clinical study.
FDA Authorizes Pfizer’s Paxlovid, First Oral Therapy for COVID-19
FDA Authorizes Pfizer’s Paxlovid, First Oral Therapy for COVID-19
Given within three days of symptom onset, the pill combination was nearly 90 percent effective at preventing high-risk patients from developing severe illness in a clinical study.
Given within three days of symptom onset, the pill combination was nearly 90 percent effective at preventing high-risk patients from developing severe illness in a clinical study.
A device that releases synthetic hormones slowly over time could one day provide a more practical alternative to daily birth control pills, say scientists.